Clorox (CLX) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $93.06 -1.3%
EPS Growth %: +30.6%
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +30.6%
Financial Fact:
Research and development costs: 31M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q4 EPS of $1.44, $0.07 better than the analyst estimate of $1.37. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.52 billion.
Clorox sees FY2016 EPS of $4.68-$4.83, versus the consensus of $4.84.
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
